Cardiovascular Division
International Study Shows Low Incidence of COVID Vaccine-Related Myocarditis, Higher Risk from Virus
Oct. 28 2022 | Share
A University of Miami Miller School of Medicine researcher is hoping an innovative multicenter clinical trial will lead to new therapies for neurofibromatosis type 2 (NF2), a devastating disease causing multiple types of tumors…
A groundbreaking clinical trial for unaffected individuals at risk for a genetic form of amyotrophic lateral sclerosis (ALS) could pave the way for early intervention strategies for other forms of…
The University of Miami Miller School of Medicine participated in the Glycemia Reduction Approaches in Diabetes (GRADE) — A Comparative Effectiveness multi-center clinical trial, marking the end of a 10-year…